These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25304064)

  • 1. [Which choice would the radiation oncologist consider if facing an advanced stage laryngeal cancer?].
    Giraud P; Malinvaud D; Ménard M; Consoli S; Bonfils P; Laccourreye O
    Cancer Radiother; 2014 Nov; 18(7):649-54. PubMed ID: 25304064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otorhinolaryngologists' personal treatment preferences (total laryngectomy or laryngeal preservation) when faced with advanced stage laryngeal cancer.
    Laccourreye O; Malinvaud D; Ménard M; Consoli S; Giraud P; Bonfils P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Dec; 131(6):339-343. PubMed ID: 24993784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences.
    Laccourreye O; Malinvaud D; Ménard M; Consoli S; Giraud P; Bonfils P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Apr; 131(2):93-7. PubMed ID: 24529928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective.
    Laccourreye O; Malinvaud D; Holsinger FC; Consoli S; Ménard M; Bonfils P
    Ann Otol Rhinol Laryngol; 2012 Sep; 121(9):570-5. PubMed ID: 23012894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
    J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and laryngeal preservation tradeoff in advanced laryngeal cancer: From the otorhinolaryngology patient to the managing physician.
    Laccourreye O; Bonfils P; Malinvaud D; Ménard M; Giraud P
    Head Neck; 2017 Oct; 39(10):1984-1989. PubMed ID: 28786181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer.
    Laccourreye O; Mirghani H; Guiquerro S; Quer M; Giraud P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Mar; 140(2):77-80. PubMed ID: 36642664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007.
    Chen AY; Fedewa S; Zhu J
    Arch Otolaryngol Head Neck Surg; 2011 Oct; 137(10):1017-24. PubMed ID: 22006780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
    ; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
    J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.
    Alterio D; Franco P; Numico G; Licitra L; Cossu Rocca M; Ferrari A; Pinto C; Russi EG; Ricardi U; Jereczek Fossa BA
    Med Oncol; 2016 Jul; 33(7):76. PubMed ID: 27290695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Larynx preservation.
    Lefebvre JL
    Curr Opin Oncol; 2012 May; 24(3):218-22. PubMed ID: 22450148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with larynx cancer in Latin America: Comparison between laryngectomy and organ preservation protocols.
    Sanabria A; Sánchez D; Chala A; Alvarez A
    Ear Nose Throat J; 2018 Mar; 97(3):83-90. PubMed ID: 29554402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
    Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in patients treated for advanced hypopharyngeal or laryngeal cancer.
    Guibert M; Lepage B; Woisard V; Rives M; Serrano E; Vergez S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):218-23. PubMed ID: 21613002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical management of supraglottic laryngeal carcinoma in 182 patients with special emphasis on functional preservation].
    Zhang L; Luan X; Pan X; Xie G; Xu F; Liu D; Lei D
    Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):59-61. PubMed ID: 11977641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comorbidity on treatment (chemoradiation and laryngectomy) of advanced, nondistant metastatic laryngeal cancer: a review of 16 849 cases from the national cancer database (2003-2008).
    Zhu J; Fedewa S; Chen AY
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1120-8. PubMed ID: 23247231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.